The Liposomal Doxorubicin Market was valued at USD 1.33 billion in 2024 and is projected to reach USD 2.23 billion by 2033, growing at a CAGR of 6.1%. Growth is driven by increasing cancer prevalence and advancements in drug delivery technologies. https://www.datamintelligence.com/research-report/liposomal-doxorubicin-market?dr